☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Xbrane
Xbrane Reports the US FDA Acceptance of BLA for Lucentis Biosimilar to Treat Serious Eye Diseases
June 21, 2023
Insights+ Key Biosimilars Events of July 2022
August 4, 2022
Xbrane Biopharma Seeks to Initiate the Development of Keytruda and Darzalex Biosimilar
December 13, 2021
Insights+ Key Biosimilars Events of July 2021
August 5, 2021
Insights+ Key Biosimilars Events of May 2021
June 3, 2021
Insights+ Key Biosimilars Events of November 2020
December 3, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
